article thumbnail

These 40 bets would deliver $30-$50 bn additional growth to healthcare sector by 2029

Express Pharma

These were further analysed and shortlisted to ensure that there is entrepreneurial, scientific, innovation and investment capability on ground to see these succeed in the run up to the next general elections by 2029. per cent increase in happiness; 0.27 years of additional life expectancy; a decrease of 0.72

article thumbnail

COPD market to reach $30.8 billion in 7MM by 2033: GlobalData

Express Pharma

Other KOLs have communicated that Dupixent is to dominate the biologics market after receiving both EMA and FDA approval, filling a gap in the COPD market. The changes made by GOLD have communicated that ICS/LABA fixed-dose combinations should not be used, which has been reflected in the COPD report, highlighting a 1.4 billion by 2033.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Top Performing Drug of 2021 - Trulicity (February Edition)

PharmaShots

In the US, Trulicity is protected by a compound patent (2027) and by biologics data protection (2026).

article thumbnail

Digitalisation of the clinical trial landscape

European Pharmaceutical Review

According to Maximize Market Research , new technologies are expected to boost the clinical trials market between 2022 to 2029, especially as the industry and patients are shifting towards digitalisation approaches and personalised medicines.

article thumbnail

AI in Life Sciences: Exploring Innovation and Opportunities

Viseven

in 2029 , with a compound annual growth rate of 27.9%. In life sciences, chatbots and virtual assistants can be used by pharmaceutical companies to improve communication with patients. The global market for AI in life sciences is projected to reach $33.5b

article thumbnail

NHC Submits Comments on FDA’s Draft Guidance for Voluntary Incorporation of Patient Preference Information

Putting Patients First Blog

17 In addition to its role in pre-market decisions, PPI can be valuable in post-market activities, including the formulation and communication of recall notices. 1 (2009): 2029. ” Journal of Health Communication 16, Suppl. ” Journal of Clinical Outcomes Management 16, no. 10 Sheridan, Stacey L., Halpern, Anthony J.

article thumbnail

Selvita and the University of Oxford join forces to tackle Parkinson’s disease

Pharmaceutical Technology

The US market is driving this growth, forecasted to nearly triple from $2.4bn in 2023 to $7.4bn by 2029, as per GlobalData. Across the seven major markets (US, UK, Japan, Germany, France, Spain and Italy) the market for Parkinson’s disease treatment is set to grow significantly over the next few years, from $4.6bn in 2023 to $11.5bn.